drugset / Trial / NCT03248297

Antibiotic Prophlaxis for High-risk Laboring Women in Low Income Countries

NCT03248297

RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study, performed over a course of 3 years in 5 collaborating hospitals in Cameroon, Africa, will randomize 750 women in labor with prolonged rupture of membranes ≥ 8 hours or prolonged labor ≥ 18 hours to identical oral regimens of 1 gram of azithromycin, 1 gram of azithromycin+2 grams of amoxicillin or placebo. Women will be followed to ascertain maternal infectious outcomes and perinatal outcomes.

Timeline

Start
2018-01-12
Primary completion
2020-05-15
Completion
2020-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified 2 g Oral
Subject Azithromycin Small molecule 1 g Oral